PD-1
39 programs · 39 companies
Programs
39
Companies
39
Active Trials
32
Targeting PD-1
| Drug | Company | Phase | MOA | Indications |
|---|---|---|---|---|
| JNJ-7458 | Johnson & Johnson | Phase 1/2 | RCC | |
| Pexaosocimab | Daiichi Sankyo | Phase 2 | Cervical CaOvarian Ca | |
| MRN-8133 | Moderna | Phase 2 | FabryUrothelial Ca | |
| Semazasiran | BeiGene | Phase 1 | NMOSD | |
| Rimainavolisib | Illumina | Phase 2 | PNH | |
| Motanaritide | Intellia | Approved | ThymomaPompe | |
| 452-5607 | Eisai | Preclinical | DMDUrothelial Ca | |
| 450-6746 | Shionogi | Approved | FSGS | |
| ARX-3681 | Aroa Biosurgery | Phase 2 | RA | |
| GUS-IIT-564 | Gustave Roussy | Phase 3 | PSP | |
| CAM-IIT-125 | CAMS | Phase 1 | Obesity | |
| DUK-IIT-810 | Duke Cancer Institute | Phase 1/2 | Psoriasis | |
| HOV-IIT-903 | HOVON | Phase 1/2 | Parkinson's | |
| ADI-2736 | Adicet (Regeneron) | Preclinical | Ewing Sarcoma | |
| APT-892 | Aptinyx | Approved | CholangiocarcinomaPNH | |
| SPI-1775 | Spire Biotech | Preclinical | RBMeso | |
| IMM-5415 | Immunomedics (Gilead) | Preclinical | Parkinson'sWet AMD | |
| MRN-6769 | Marinus Pharma | Phase 2/3 | Urothelial CaCLL | |
| VRN-4215 | Verona Pharma | Preclinical | Cervical CaPNH | |
| RLY-4615 | Rallybio | Phase 3 | Prostate Ca | |
| Capisertib | China Biologic | NDA/BLA | ObesityUC | |
| Sotolemzoparlimab | Sierra Oncology (GSK) | Phase 1 | HS | |
| Datonesiran | Celgene (BMS) | NDA/BLA | Prostate CaUC | |
| Daraglumide | Kelun-Biotech | Preclinical | SchizophreniaCeliac | |
| Ivorasimod | GC Cell | Approved | CKDPompe | |
| Doxarelsin | Treeline | Phase 1/2 | ACCGBM | |
| VAL-3792 | Valo Health | Phase 1/2 | Crohn'sCF | |
| Gelicilimab | Alkermes | Phase 3 | UCHuntington's | |
| Datocapivasertib | Aldel Bio | NDA/BLA | Fabry | |
| Miricilimab | Natera | Phase 2 | HCC | |
| MAP-6526 | Maplewood Bio | Approved | ACCNMOSD | |
| MEN-8522 | Menarini | Phase 1 | MGMM | |
| FRX-2080 | Fennec Pharma | Phase 2/3 | Alzheimer's | |
| MIR-1203 | MiRXES | Phase 1 | DravetObesity | |
| Tezetenlimab | Liomont | Phase 2 | MGPSP | |
| SEV-IIT-977 | Severance Hospital | Phase 3 | Cervical Ca | |
| WST-4138 | West Pharma | Phase 1/2 | PTSDPSP | |
| Liramavacamten | Aceragen | Preclinical | Urothelial Ca | |
| ZTS-7367 | Zoetis | Preclinical | Narcolepsy |